Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    CD99 Antibody (MEM-131), Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB500403
Description
CD99 Monoclonal specifically detects CD99 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Paraffin.Specifications
| CD99 | |
| Monoclonal | |
| 1 mg/mL | |
| Western Blot 1:1000, Flow Cytometry 1 ug/ml, Immunohistochemistry 1:10-1:500, Immunoprecipitation 1:50, Immunohistochemistry-Paraffin 10 ug/ml | |
| 12E7, CD99 antigenY homolog, CD99 molecule, E2 antigen, HBA71, MIC2 (monoclonal 12E7), MIC2Y, MSK5X, Protein MIC2, surface antigen MIC2, T-cell surface glycoprotein E2 | |
| Mouse | |
| Affinity Purified | |
| RUO | |
| Primary | |
| The antibody MEM-131 reacts with CD99R, an epitope restricted to a subset of CD99 molecule expressed on myeloid cells, NK cells and T lymphocytes. HLDA V; WS Code AS S020 HLDA V; WS Code T T-E2.02 HLDA V; WS Code T T-017 | |
| Store at 4C. Do not freeze. | 
| Western Blot, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Paraffin) | |
| MEM-131 | |
| Unconjugated | |
| P14209 | |
| CD99 | |
| HPB-ALL human peripheral blood leukemia T-cell line | |
| 0.1 mg | |
| Immunology | |
| 4267 | |
| Human | |
| IgM | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            For Research Use Only
Spot an opportunity for improvement?Share a Content Correction